Cargando…
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Cancer has been considered, for a long time, a genetic disease where mutations in key regulatory genes drive tumor initiation, growth, metastasis, and drug resistance. Instead, the advent of high-throughput technologies has revolutionized cancer research, allowing to investigate molecular alteration...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721562/ https://www.ncbi.nlm.nih.gov/pubmed/31366176 http://dx.doi.org/10.3390/cells8080798 |